🇺🇸 FDA
Company

CG

CG Oncology

CGON biotech USA

Quick answer

CG is a biotech company (CGON) headquartered in DALLAS, TX, USA with 8 tracked pipeline programs.

Pipeline (8)

project

CG0070 Adenovirus Vector

Transitional Cell Carcinoma

Phase 3 · mab · terminated

1 trials project

Cretostimogene Grenadenorepvec

Non Muscle Invasive Bladder Cancer

Phase 3 · mab · active

2 trials project

CG0070

Bladder Cancer

Phase 2 · mab · completed

1 trials project

CG0070

Non Muscle Invasive Bladder Cancer

Phase 2 · mab · completed

1 trials project

Cretostimogene Grenadenorepvec

High-Risk Non-Muscle-Invasive Bladder Cancer

Phase 2 · small_molecule · active

1 trials project

Ivaltinostat

Metastatic Pancreatic Adenocarcinoma

Phase 2 · small_molecule · active

1 trials project

oncolytic adenovirus expressing GMCSF

Bladder Cancer

Phase 2 · mab · terminated

1 trials project

CG0070

Muscle-Invasive Bladder Carcinoma

Phase 1 · small_molecule · completed

1 trials

Patents (5)

patent

US 12370229

Methods of treating bladder cancer

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12090183

Methods of treating solid or lymphatic tumors by combination therapy

Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11596660

Methods of treating bladder cancer

Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11497781

Methods of treating bladder cancer by combination therapy comprising the oncolyt

Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11338003

Methods of treating bladder cancer with an oncolytic virus

Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)